Rational design of vaccines for AIDS and influenza.

Gary J. Nabel

Research output: Contribution to journalArticle

Abstract

Successful immunization against challenging infectious diseases requires novel approaches to vaccine design. To control diseases of high human health impact such as AIDS and influenza by vaccination requires an understanding of the mechanisms of viral entry and identification of highly conserved vulnerable regions of the virus to which immune responses are not normally directed. Structural biology has provided important information about the three-dimensional organization and chemical structure of the HIV-1 and influenza glycoproteins. By harnessing structural biology, monoclonal antibody specificity, genomics, and informatics, we have been able to define neutralizing antibodies of exceptional breadth and potency against circulating strains of HIV-1, and we have begun to develop immunogens to elicit such antibodies. Similarly, for influenza, understanding of this target has led to structural and genetic approaches to the development of new immunogens that provide a proof of concept for universal influenza vaccination.

Original languageEnglish (US)
JournalTransactions of the American Clinical and Climatological Association
Volume123
StatePublished - 2012
Externally publishedYes

Fingerprint

AIDS Vaccines
Influenza Vaccines
Human Influenza
HIV-1
Vaccination
Informatics
Antibody Specificity
Genomics
Neutralizing Antibodies
Communicable Diseases
Immunization
Glycoproteins
Acquired Immunodeficiency Syndrome
Vaccines
Monoclonal Antibodies
Viruses
Antibodies
Health

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rational design of vaccines for AIDS and influenza. / Nabel, Gary J.

In: Transactions of the American Clinical and Climatological Association, Vol. 123, 2012.

Research output: Contribution to journalArticle

@article{2afccc7fad45478881cda874e2870096,
title = "Rational design of vaccines for AIDS and influenza.",
abstract = "Successful immunization against challenging infectious diseases requires novel approaches to vaccine design. To control diseases of high human health impact such as AIDS and influenza by vaccination requires an understanding of the mechanisms of viral entry and identification of highly conserved vulnerable regions of the virus to which immune responses are not normally directed. Structural biology has provided important information about the three-dimensional organization and chemical structure of the HIV-1 and influenza glycoproteins. By harnessing structural biology, monoclonal antibody specificity, genomics, and informatics, we have been able to define neutralizing antibodies of exceptional breadth and potency against circulating strains of HIV-1, and we have begun to develop immunogens to elicit such antibodies. Similarly, for influenza, understanding of this target has led to structural and genetic approaches to the development of new immunogens that provide a proof of concept for universal influenza vaccination.",
author = "Nabel, {Gary J.}",
year = "2012",
language = "English (US)",
volume = "123",
journal = "Transactions of the American Clinical and Climatological Association",
issn = "0065-7778",
publisher = "American Clinical And Climatological Association",

}

TY - JOUR

T1 - Rational design of vaccines for AIDS and influenza.

AU - Nabel, Gary J.

PY - 2012

Y1 - 2012

N2 - Successful immunization against challenging infectious diseases requires novel approaches to vaccine design. To control diseases of high human health impact such as AIDS and influenza by vaccination requires an understanding of the mechanisms of viral entry and identification of highly conserved vulnerable regions of the virus to which immune responses are not normally directed. Structural biology has provided important information about the three-dimensional organization and chemical structure of the HIV-1 and influenza glycoproteins. By harnessing structural biology, monoclonal antibody specificity, genomics, and informatics, we have been able to define neutralizing antibodies of exceptional breadth and potency against circulating strains of HIV-1, and we have begun to develop immunogens to elicit such antibodies. Similarly, for influenza, understanding of this target has led to structural and genetic approaches to the development of new immunogens that provide a proof of concept for universal influenza vaccination.

AB - Successful immunization against challenging infectious diseases requires novel approaches to vaccine design. To control diseases of high human health impact such as AIDS and influenza by vaccination requires an understanding of the mechanisms of viral entry and identification of highly conserved vulnerable regions of the virus to which immune responses are not normally directed. Structural biology has provided important information about the three-dimensional organization and chemical structure of the HIV-1 and influenza glycoproteins. By harnessing structural biology, monoclonal antibody specificity, genomics, and informatics, we have been able to define neutralizing antibodies of exceptional breadth and potency against circulating strains of HIV-1, and we have begun to develop immunogens to elicit such antibodies. Similarly, for influenza, understanding of this target has led to structural and genetic approaches to the development of new immunogens that provide a proof of concept for universal influenza vaccination.

UR - http://www.scopus.com/inward/record.url?scp=84879478359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879478359&partnerID=8YFLogxK

M3 - Article

C2 - 23303965

AN - SCOPUS:84879478359

VL - 123

JO - Transactions of the American Clinical and Climatological Association

JF - Transactions of the American Clinical and Climatological Association

SN - 0065-7778

ER -